SUMMARIZED CONDENSED CONSOLIDATING INFORMATION - Condensed Consolidating Statement of Cash Flows (unaudited) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	$ 49,771	$ 133,816
Cash flows from investing activities:
Acquisition of real estate	(393,064)	(109,619)
Cash received in CCP Merger	77,858	0
Origination and fundings of loans receivable	(5,642)	(9,478)
Origination and fundings of preferred equity investments	(2,713)	(6,845)
Additions to real estate	(3,233)	(901)
Repayment of loans receivable	8,710	214,947
Repayments of preferred equity investments	3,239	0
Investment in subsidiaries		0
Net proceeds from the sales of real estate	11,723	85,449
Distribution from subsidiaries	0	0
Intercompany financing	0	0
Net cash (used in) provided by investing activities	(303,122)	173,553
Cash flows from financing activities:
Net repayments of revolving credit facility	(137,000)	(255,000)
Proceeds from term loans	181,000	69,360
Principal payments on secured debt	(3,094)	(13,756)
Payments of deferred financing costs	(15,316)	(5,933)
Issuance of common stock, net	319,026	(1,289)
Dividends paid on common and preferred stock	(86,813)	(89,283)
Contribution from parent		0
Distribution to parent	0	0
Intercompany financing	0	0
Net cash provided by (used in) financing activities	257,803	(295,901)
Net increase in cash and cash equivalents	4,452	11,468
Effect of foreign currency translation on cash and cash equivalents	758	772
Cash and cash equivalents, beginning of period	25,663	7,434
Cash and cash equivalents, end of period	30,873	19,674
Elimination [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Acquisition of real estate	0	0
Cash received in CCP Merger	0
Origination and fundings of loans receivable	0	0
Origination and fundings of preferred equity investments	0	0
Additions to real estate	0	0
Repayment of loans receivable	0	0
Repayments of preferred equity investments	0
Investment in subsidiaries		400
Net proceeds from the sales of real estate	0	0
Distribution from subsidiaries	(4,948)	(12,808)
Intercompany financing	720,772	(179,954)
Net cash (used in) provided by investing activities	715,824	(192,362)
Cash flows from financing activities:
Net repayments of revolving credit facility	0	0
Proceeds from term loans	0	0
Principal payments on secured debt	0	0
Payments of deferred financing costs	0	0
Issuance of common stock, net	0	0
Dividends paid on common and preferred stock	0	0
Contribution from parent		(400)
Distribution to parent	4,948	12,808
Intercompany financing	(720,772)	179,954
Net cash provided by (used in) financing activities	(715,824)	192,362
Net increase in cash and cash equivalents	0	0
Effect of foreign currency translation on cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	40,567	113,886
Cash flows from investing activities:
Acquisition of real estate	0	0
Cash received in CCP Merger	77,858
Origination and fundings of loans receivable	0	0
Origination and fundings of preferred equity investments	0	0
Additions to real estate	(22)	(124)
Repayment of loans receivable	0	0
Repayments of preferred equity investments	0
Investment in subsidiaries		(200)
Net proceeds from the sales of real estate	0	0
Distribution from subsidiaries	2,474	6,404
Intercompany financing	(346,044)	(17,684)
Net cash (used in) provided by investing activities	(265,734)	(11,604)
Cash flows from financing activities:
Net repayments of revolving credit facility	0	0
Proceeds from term loans	0	0
Principal payments on secured debt	0	0
Payments of deferred financing costs	0	0
Issuance of common stock, net	319,026	(1,289)
Dividends paid on common and preferred stock	(86,813)	(89,283)
Contribution from parent		0
Distribution to parent	0	0
Intercompany financing	0	0
Net cash provided by (used in) financing activities	232,213	(90,572)
Net increase in cash and cash equivalents	7,046	11,710
Effect of foreign currency translation on cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	18,168	2,548
Cash and cash equivalents, end of period	25,214	14,258
Issuers [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Acquisition of real estate	0	0
Cash received in CCP Merger	0
Origination and fundings of loans receivable	0	0
Origination and fundings of preferred equity investments	0	0
Additions to real estate	0	0
Repayment of loans receivable	0	0
Repayments of preferred equity investments	0
Investment in subsidiaries		(200)
Net proceeds from the sales of real estate	0	0
Distribution from subsidiaries	2,474	6,404
Intercompany financing	(374,728)	197,638
Net cash (used in) provided by investing activities	(372,254)	203,842
Cash flows from financing activities:
Net repayments of revolving credit facility	(137,000)	(255,000)
Proceeds from term loans	181,000	45,000
Principal payments on secured debt	0	0
Payments of deferred financing costs	(15,316)	(5,322)
Issuance of common stock, net	0	0
Dividends paid on common and preferred stock	0	0
Contribution from parent		200
Distribution to parent	(2,474)	(6,404)
Intercompany financing	346,044	17,684
Net cash provided by (used in) financing activities	372,254	(203,842)
Net increase in cash and cash equivalents	0	0
Effect of foreign currency translation on cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Sabra Capital Corporation [Member] | Combined Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	0	0
Cash flows from investing activities:
Acquisition of real estate	0	0
Cash received in CCP Merger	0
Origination and fundings of loans receivable	0	0
Origination and fundings of preferred equity investments	0	0
Additions to real estate	0	0
Repayment of loans receivable	0	0
Repayments of preferred equity investments	0
Investment in subsidiaries		0
Net proceeds from the sales of real estate	0	0
Distribution from subsidiaries	0	0
Intercompany financing	0	0
Net cash (used in) provided by investing activities	0	0
Cash flows from financing activities:
Net repayments of revolving credit facility	0	0
Proceeds from term loans	0	0
Principal payments on secured debt	0	0
Payments of deferred financing costs	0	0
Issuance of common stock, net	0	0
Dividends paid on common and preferred stock	0	0
Contribution from parent		0
Distribution to parent	0	0
Intercompany financing	0	0
Net cash provided by (used in) financing activities	0	0
Net increase in cash and cash equivalents	0	0
Effect of foreign currency translation on cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Combined Guarantor Subsidiaries of 2021 Notes and 2023 Notes [Member] | Combined Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	4,122	10,683
Cash flows from investing activities:
Acquisition of real estate	(393,064)	(109,619)
Cash received in CCP Merger	0
Origination and fundings of loans receivable	(1,488)	(9,478)
Origination and fundings of preferred equity investments	(2,713)	(6,845)
Additions to real estate	(2,847)	(400)
Repayment of loans receivable	2,221	214,947
Repayments of preferred equity investments	3,239
Investment in subsidiaries		0
Net proceeds from the sales of real estate	11,328	85,449
Distribution from subsidiaries	0	0
Intercompany financing	0	0
Net cash (used in) provided by investing activities	(383,324)	174,054
Cash flows from financing activities:
Net repayments of revolving credit facility	0	0
Proceeds from term loans	0	24,360
Principal payments on secured debt	0	(10,766)
Payments of deferred financing costs	0	(611)
Issuance of common stock, net	0	0
Dividends paid on common and preferred stock	0	0
Contribution from parent		0
Distribution to parent	0	0
Intercompany financing	377,458	(197,638)
Net cash provided by (used in) financing activities	377,458	(184,655)
Net increase in cash and cash equivalents	(1,744)	82
Effect of foreign currency translation on cash and cash equivalents	83	756
Cash and cash equivalents, beginning of period	2,675	1,008
Cash and cash equivalents, end of period	1,014	1,846
Combined Non-Guarantor Subsidiaries of 2021 Notes and 2023 Notes [Member] | Combined Non-Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	5,082	9,247
Cash flows from investing activities:
Acquisition of real estate	0	0
Cash received in CCP Merger	0
Origination and fundings of loans receivable	(4,154)	0
Origination and fundings of preferred equity investments	0	0
Additions to real estate	(364)	(377)
Repayment of loans receivable	6,489	0
Repayments of preferred equity investments	0
Investment in subsidiaries		0
Net proceeds from the sales of real estate	395	0
Distribution from subsidiaries	0	0
Intercompany financing	0	0
Net cash (used in) provided by investing activities	2,366	(377)
Cash flows from financing activities:
Net repayments of revolving credit facility	0	0
Proceeds from term loans	0	0
Principal payments on secured debt	(3,094)	(2,990)
Payments of deferred financing costs	0	0
Issuance of common stock, net	0	0
Dividends paid on common and preferred stock	0	0
Contribution from parent		200
Distribution to parent	(2,474)	(6,404)
Intercompany financing	(2,730)	0
Net cash provided by (used in) financing activities	(8,298)	(9,194)
Net increase in cash and cash equivalents	(850)	(324)
Effect of foreign currency translation on cash and cash equivalents	675	16
Cash and cash equivalents, beginning of period	4,820	3,878
Cash and cash equivalents, end of period	$ 4,645	$ 3,570